SEARCH

SEARCH BY CITATION

References

  • Andersen P & Doherty TM (2005) The success and failure of BCG-implications for a novel tuberculosis vaccine. Nat Rev Microbiol 3: 656662.
  • Bardarov S, Bardarov S Jr, Pavelka MS Jr, Sambandamurthy V, Larsen M, Tufariello J, Chan J, Hatfull G & Jacobs WR Jr (2002) Specialized transduction: an efficient method for generating marked and unmarked targeted gene disruptions in Mycobacterium tuberculosis, M. bovis BCG and M. smegmatis. Microbiology 148: 30073017.
  • Charles C & Shepard MD (1960) The experimental disease that follows the injection of human leprosy bacilli into foot-pads of mice. J Exp Med 112: 445454.
  • Clements DL, Lee BY & Horwitz MA (1995) Purification, characterization, and genetic-analysis of Mycobacterium tuberculosis urease, a potentially critical determinant of host-pathogen interaction. J Bacteriol 177: 56445652.
  • Dockrell HM, Young SK, Britton K et al. (1996) Induction of Th1 cytokine responses by mycobacterial antigens in leprosy. Infect Immun 64: 43854389.
  • Dye C, Watt CJ, Bleed DM, Hosseini SM & Raviglione MC (2005) Evolution of tuberculosis control and prospects for reducing tuberculosis incidence, prevalence, and deaths globally. JAMA 293: 27672775.
  • Granelli-Piperno A, Golebiowska A, Trumpfheller C, Siegal FP & Steinman RM (2004) HIV-1-infected monocyte-derived dendritic cells do not undergo maturation but can elicit IL-10 production and T cell regulation. Proc Natl Acad Sci USA 101: 76697674.
  • Grode L, Seiler P, Baumann S et al. (2005) Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guérin mutants that secrete listeriolysin. J Clin Investig 115: 24722479.
  • Hashimoto K, Maeda Y, Kimura H, Suzuki K, Masuda A, Matsuoka M & Makino M (2002) Mycobacterium leprae infection in monocyte-derived dendritic cells and its influence on antigen-presenting function. Infect Immunity 70: 51675176.
  • Honerzu Bentrup K & Russell DG (2001) Mycobacterial persistence: adaptation to a changing environment [review]. Trends Microbiol 9: 597605.
  • Job CK (1989) Nerve damage in leprosy. Int J Lepr Other Mycobact Dis 57: 532539.
  • Kai M, Maeda Y, Maeda S, Fukutomi Y, Kobayashi K, Kashiwabara Y, Makino M, Abbasi MA, Khan MZ & Shah PA (2004) Active surveillance of leprosy contacts in country with low prevalence rate. Int J Lepr Other Mycobact Dis 72: 5053.
  • Kaufmann SHE (2005) Introduction. Rational vaccine development against tuberculosis: “those who don't remember the past are condemned to repeat it”. Microbes Infect 7: 897898.
  • Kaufmann SHE (2006) Envisioning future strategies for vaccination against tuberculosis. Nat Rev Immunol 6: 699704.
  • Kaufmann SHE & McMichael AJ (2005) Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis. Nat Med 11: S33S44.
  • Maeda S, Matsuoka M, Nakata N, Kai M, Maeda Y, Hashimoto K, Kimura H, Kobayashi K & Kashiwabara Y (2001) Multidrug resistant Mycobacterium leprae from patients with leprosy. Antimicrob Agents Chemother 45: 36353639.
  • Maeda Y, Gidoh M, Ishii N, Mukai C & Makino M (2003) Assessment of cell mediated immunogenicity of Mycobacterium leprae-derived antigens. Cell Immunol 222: 6977.
  • Makino M & Baba M (1997) A cryopreservation method of human peripheral blood mononuclear cells for efficient production of dendritic cells. Scand J Immunol 45: 618622.
  • Makino M, Shimokubo S, Wakamatsu S, Izumo S & Baba M (1999) The role of human T-lymphotropic virus type 1 (HTLV-1)-infected dendritic cells in the development of HTLV-1-associated myelopathy/tropical spastic paraparesis. J Virol 73: 45754581.
  • Makino M, Maeda Y, Fukutomi Y & Mukai T (2007) Contribution of GM-CSF on the enhancement of the T cell-stimulating activity of macrophages. Microbes Infect 9: 7077.
  • McDermott-Lancaster RD, Ito T, Kohsaka K, Guelpa-Lauras CC & Grosset JH (1987) Multiplication of Mycobacterium leprae in the nude mouse, and some applications of nude mice to experimental leprosy. Int J Lepr Other Mycobact Dis 55: 889895.
  • Miyamoto Y, Mukai T, Takeshita F, Nakata N, Maeda Y, Kai M & Makino M (2004) Aggregation of mycobacteria caused by disruption of fibronectin-attachment protein-encoding gene. FEMS Microbiol Lett 236: 227234.
  • Miyamoto Y, Mukai T, Nakata N, Maeda Y, Kai M, Naka T, Yano I & Makino M (2006) Identification and characterization of the genes involved in glycosylation pathways of mycobacterial glycopeptidolipid biosynthesis. J Bacteriol 188: 8695.
  • Mochida-Nishimura K, Akagawa KS & Rich EA (2001) Interleukin-10 contributes development of macrophage suppressor activities by macrophage colony-stimulating factor, but not by granulocyte-macrophage colony-stimulating factor. Cell Immunol 214: 8188.
  • Orme IM, Roberts AD, Griffin JP & Abrams JS (1993) Cytokine secretion by CD4 T lymphocytes acquired in response to Mycobacterium tuberculosis infection. J Immunol 151: 518525.
  • Reyrat JM, Berthet FX & Gicquel B (1995) The urease locus of Mycobacterium tuberculosis and its utilization for the demonstration of allelic exchange in Mycobacterium bovis bacillus Calmette-Guérin. Proc Natl Acad Sci USA 92: 87688772.
  • Schaible UE, Sturgill-Koszycki S, Schlesinger PH & Russell DG (1998) Cytokine activation leads to acidification and increases maturation of Mycobacterium avium-containing phagosomes in murine macrophages. J Immunol 160: 12901296.
  • Sendide K, Degmane AE, Reyrat JM, Talal A & Hmama Z (2004) Mycobacterium bovis BCG urease attenuates major histocompatibility complex class II trafficking to the macrophage cell surface. Infect Immun 72: 42004209.
  • Setia MS, Steinmaus C, Ho CH & Rutherford GW (2006) The role of BCG in prevention of leprosy: a meta-analysis. Lancet Infect Dis 6: 162170.
  • Stoner GL (1979) Importance of the neural predilection of Mycobacterium leprae in leprosy. Lancet 2: 994996.
  • Verreck FA, De Boer T, Langenberg DM, Hoeve MA, Kramer M, Vaisberg E, Kastelein R, Kolk A, De Waal-Malefyt R & Ottenhoff TH (2004) Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria. Proc Natl Acad Sci USA 101: 45604565.
  • Wakamatsu S, Makino M, Tei C & Baba M (1999) Monocyte-driven activation-induced apoptotic cell death of human T-lymphotropic virus type I-infected T cells. J Immunol 163: 39143919.
  • World Health Organization. (2006) Fact Sheet No. 104, Rev March, http://www.who.int/mediacentre/factsheets/fs104/en